2026 Review: Cannabinoids in Managing MS Spasticity
This 2026 systematic review evaluates cannabinoids for MS spasticity, finding modest improvements with THC:CBD extracts. Despite low evidence certainty, cannabinoids may aid some patients with MS spasticity as adjunctive therapy. Careful clinical…
THC:CBD Oil for Spinal Cord Injury Spasticity- What a Pilot Trial Found
THC CBD oil for spinal cord injury spasticity: A placebo-controlled crossover pilot tested balanced THC:CBD oil in 16 people with chronic spinal cord injury. The objective primary spasticity measure did not significantly improve, while one patient-rated…
Cannabinoids for MS Spasticity: What 27 Randomized Trials Show
cannabinoids for MS spasticity: A systematic review of 27 randomized trials found modest patient-reported improvement in multiple-sclerosis spasticity, especially with THC:CBD extracts. Objective benefits were limited and the certainty of evidence was…
Medical Cannabis Beyond Pain: PM&R Review on Spasticity, Seizures, Sleep & Nausea
A PM&R-focused narrative review examines medical cannabis non-pain indications including spasticity, seizures, sleep disturbances, and chemotherapy-induced nausea. While patient-reported symptom benefits are noted, evidence for functional outcome…
Long-Term Cannabis Therapy May Change MS Spasticity Outcomes
Cannabis for MS spasticity was associated with meaningful symptom improvement in a new meta-analysis involving 2,544 multiple sclerosis patients across nine trials. The strongest benefits emerged with longer treatment duration, while short-term effects…
Enhancing the endocannabinoid system to treat residual disease in relapse-free multiple sclerosis.
A new consensus from Italian neurologists proposes enhancing the endocannabinoid system multiple sclerosis treatment approach for patients with relapse-free disease. The algorithm combines cannabinoid agents with lifestyle interventions to address…
Persistent and Debilitating Muscle Spasms | Utah Medical Cannabis Guidelines
Utah's spasticity clinical guidelines provide evidence-based protocols for medical cannabis use in persistent and debilitating muscle spasms. These guidelines help clinicians with dosing and delivery methods for spasticity management. Patients with…
Over 70% of MS Patients in Rehab Take 5+ Medications, Study Finds
Polypharmacy in MS rehabilitation is a significant clinical challenge, with over 70% of patients taking five or more medications. This study highlights the potential for cannabis to consolidate therapies and reduce drug interactions. Understanding…
Honoring the Trailblazers with MS Who Changed Cannabis Policy
Multiple sclerosis cannabis advocacy has played a pivotal role in shaping medical cannabis policy. MS patients were among the first to demonstrate therapeutic benefits of cannabinoids in clinical settings. Their efforts helped establish evidence-based…
MS Cases Double in England Over 20 Years; Life Expectancy Rises
Multiple sclerosis spasticity cannabis treatments are gaining attention as MS cases double in England over 20 years. Improved survival rates mean more patients live longer with chronic symptoms. Cannabis therapies offer promising options for managing…